SW · Healthcare

MINDMAZE THERAPEUTICS HOLDING SA (MMTX)

Biotechnology

MINDMAZE THERAPEUTICS HOLDING SA (MMTX) is listed on SW in the Healthcare sector. Industry: Biotechnology. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for MMTX

P/E ratio

18.00

MINDMAZE THERAPEUTICS HOLDING SA (MMTX) — FAQ

What is MMTX's P/E ratio?

The price-to-earnings (P/E) ratio for MINDMAZE THERAPEUTICS HOLDING SA (MMTX) is 18.00 (data as of 2026-03-22).

Does MINDMAZE THERAPEUTICS HOLDING SA pay a dividend?

Dividend yield is not available in the current snapshot for MINDMAZE THERAPEUTICS HOLDING SA (MMTX). Check the MyAverix Finance app for the latest dividend data.

What sector is MINDMAZE THERAPEUTICS HOLDING SA in?

MINDMAZE THERAPEUTICS HOLDING SA (MMTX) is classified in the Healthcare sector (Biotechnology industry).

What exchange is MMTX listed on?

MMTX is listed on SW.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)